See more : Otto Energy Limited (OTTEF) Income Statement Analysis – Financial Results
Complete financial analysis of Medicamen Biotech Limited (MEDICAMEQ.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medicamen Biotech Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Daito Koun Co.,Ltd. (9367.T) Income Statement Analysis – Financial Results
- Panasonic Holdings Corporation (PCRFY) Income Statement Analysis – Financial Results
- HTG Molecular Diagnostics, Inc. (HTGMQ) Income Statement Analysis – Financial Results
- SRG Mining Inc. (SRG.V) Income Statement Analysis – Financial Results
- Rakuten Group, Inc. (4755.T) Income Statement Analysis – Financial Results
Medicamen Biotech Limited (MEDICAMEQ.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.medicamen.com
About Medicamen Biotech Limited
Medicamen Biotech Limited manufactures and sells pharmaceutical formulations in India. The company offers its products in various forms, including tablets, capsules, liquid and dry syrups, and ointments. It also provides oral rehydration solution, mouth wash, and dental care products. The company was incorporated in 1993 and is based in New Delhi, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.79B | 1.41B | 1.15B | 1.13B | 1.26B | 1.23B | 1.12B | 824.56M | 672.76M | 777.94M | 732.49M | 639.98M | 1.01B | 1.23B | 1.02B | 863.35M | 769.33M |
| Cost of Revenue | 941.05M | 720.93M | 674.58M | 792.00M | 904.69M | 911.89M | 787.82M | 565.01M | 488.63M | 582.38M | 547.53M | 499.50M | 801.48M | 991.23M | 768.54M | 642.56M | 596.50M |
| Gross Profit | 852.01M | 687.74M | 479.88M | 335.16M | 350.35M | 314.16M | 327.25M | 259.54M | 184.13M | 195.56M | 184.96M | 140.48M | 203.79M | 238.50M | 247.57M | 220.79M | 172.83M |
| Gross Profit Ratio | 47.52% | 48.82% | 41.57% | 29.74% | 27.92% | 25.62% | 29.35% | 31.48% | 27.37% | 25.14% | 25.25% | 21.95% | 20.27% | 19.39% | 24.36% | 25.57% | 22.46% |
| Research & Development | 0.00 | 14.11M | 10.51M | 6.86M | 7.72M | 2.99M | 5.55M | 4.18M | 1.85M | 1.34M | 1.19M | 1.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.85M | 2.65M | 44.83M | 35.57M | 47.89M | 38.33M | 44.76M | 54.00M | 45.46M | 52.73M | 50.59M | 49.71M | 98.95M | 56.21M | 48.78M | 0.00 | 0.00 |
| Selling & Marketing | 27.53M | 7.18M | 32.38M | 5.96M | 4.68M | 8.93M | 14.80M | 20.69M | 24.16M | 25.62M | 22.19M | 18.43M | 0.00 | 44.09M | 57.61M | 0.00 | 0.00 |
| SG&A | 335.17M | 218.24M | 77.20M | 41.53M | 52.57M | 47.25M | 59.56M | 74.70M | 69.62M | 78.35M | 72.78M | 68.14M | 98.95M | 100.30M | 106.39M | 0.00 | 0.00 |
| Other Expenses | 0.00 | 24.62M | 1.28M | 1.21M | -810.01K | 724.66K | 1.31M | 36.38K | 167.47K | 698.03K | 75.99M | 2.35M | 122.40K | 91.16M | 77.13M | 189.38M | 138.76M |
| Operating Expenses | 335.17M | 512.69M | 289.89M | 160.41M | 177.60M | 159.68M | 179.87M | 162.92M | 147.81M | 165.80M | 148.77M | 158.82M | 196.63M | 191.47M | 183.52M | 189.38M | 138.76M |
| Cost & Expenses | 1.28B | 1.23B | 964.46M | 952.41M | 1.08B | 1.07B | 967.69M | 727.93M | 636.44M | 748.19M | 696.30M | 658.32M | 998.12M | 1.18B | 952.06M | 831.95M | 735.26M |
| Interest Income | 7.24M | 7.21M | 1.35M | 1.53M | 3.20M | 9.25M | 1.95M | 733.00K | 1.38M | 2.12M | 1.37M | 2.15M | 1.48M | 795.53K | 594.67K | 275.80K | 0.00 |
| Interest Expense | 43.97M | 29.23M | 14.01M | 10.64M | 5.69M | 9.38M | 24.08M | 30.32M | 31.01M | 28.13M | 28.96M | 26.05M | 19.15M | 17.72M | 12.24M | 13.87M | 15.31M |
| Depreciation & Amortization | 70.93M | 72.75M | 57.71M | 25.20M | 24.99M | 22.14M | 20.58M | 19.22M | 18.97M | 20.97M | 16.09M | 15.77M | 15.02M | 13.71M | 11.65M | 10.34M | 8.95M |
| EBITDA | 245.66M | 277.12M | 258.07M | 204.25M | 214.11M | 211.19M | 186.70M | 118.91M | 62.29M | 61.41M | 58.34M | -6.93M | 27.74M | 74.50M | 82.95M | 40.83M | 43.02M |
| EBITDA Ratio | 13.70% | 18.69% | 22.47% | 18.00% | 16.74% | 16.83% | 16.46% | 13.72% | 8.49% | 6.33% | 6.11% | -1.17% | 2.76% | 6.06% | 8.16% | 4.83% | 5.59% |
| Operating Income | 516.84M | 176.32M | 178.96M | 168.25M | 168.21M | 154.48M | 147.38M | 63.55M | 7.12M | 1.18M | 1.79M | -48.76M | -6.55M | 43.07M | 59.05M | 17.54M | 18.76M |
| Operating Income Ratio | 28.82% | 12.52% | 15.50% | 14.93% | 13.40% | 12.60% | 13.22% | 7.71% | 1.06% | 0.15% | 0.24% | -7.62% | -0.65% | 3.50% | 5.81% | 2.03% | 2.44% |
| Total Other Income/Expenses | -386.09M | -285.50M | -265.37M | -149.47M | 7.05M | 20.75M | -8.38M | -33.09M | -29.27M | -28.23M | -58.60M | -33.89M | 122.40K | -200.00 | -4.69M | -16.78M | 0.00 |
| Income Before Tax | 130.76M | 170.45M | 180.94M | 163.94M | 179.80M | 175.23M | 139.00M | 63.59M | 7.12M | 1.21M | 1.79M | -48.76M | -6.43M | 43.07M | 59.05M | 17.54M | 18.76M |
| Income Before Tax Ratio | 7.29% | 12.10% | 15.67% | 14.54% | 14.33% | 14.29% | 12.47% | 7.71% | 1.06% | 0.16% | 0.24% | -7.62% | -0.64% | 3.50% | 5.81% | 2.03% | 2.44% |
| Income Tax Expense | 35.82M | 23.17M | 31.97M | 42.65M | 46.89M | 54.97M | 37.87M | 11.99M | 2.31M | -3.20M | 845.40K | 520.71K | 1.81M | 15.30M | 19.29M | 3.76M | 3.66M |
| Net Income | 109.31M | 148.44M | 148.98M | 121.29M | 132.91M | 120.26M | 101.13M | 51.60M | 4.81M | 4.41M | 941.82K | -49.28M | -8.25M | 27.77M | 39.76M | 13.77M | 15.10M |
| Net Income Ratio | 6.10% | 10.54% | 12.90% | 10.76% | 10.59% | 9.81% | 9.07% | 6.26% | 0.71% | 0.57% | 0.13% | -7.70% | -0.82% | 2.26% | 3.91% | 1.60% | 1.96% |
| EPS | 8.63 | 11.92 | 12.19 | 9.93 | 10.88 | 10.28 | 9.03 | 4.95 | 0.48 | 0.49 | 0.11 | -5.88 | -1.04 | 3.59 | 5.15 | 1.78 | 1.96 |
| EPS Diluted | 8.63 | 11.92 | 12.19 | 9.93 | 10.88 | 10.28 | 9.03 | 4.95 | 0.48 | 0.49 | 0.11 | -5.88 | -1.04 | 3.59 | 5.15 | 1.78 | 1.96 |
| Weighted Avg Shares Out | 12.66M | 12.46M | 12.22M | 12.22M | 12.22M | 11.70M | 11.20M | 10.42M | 9.92M | 9.03M | 8.49M | 8.38M | 7.90M | 7.73M | 7.72M | 7.72M | 7.70M |
| Weighted Avg Shares Out (Dil) | 12.66M | 12.46M | 12.22M | 12.22M | 12.22M | 11.70M | 11.20M | 10.42M | 9.92M | 9.03M | 8.49M | 8.38M | 7.90M | 7.73M | 7.72M | 7.72M | 7.70M |
No news found for: MEDICAMEQ.NS
Source: https://incomestatements.info
Category: Stock Reports